US › Healthcare

Icecure Medical (ICCM)

US · Healthcare · Medical Devices

$1.99-3.40%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$907,000

Revenue YoY

+72.8%

Net profit

$-4.5M

EPS

$-3.11

EPS estimate

$-1.37

Net margin

-496.3%

EPS came in at -3.11 against a street estimate of -1.37 — a miss of 127.0%.

Key statistics

Market cap

$7.1M

Forward P/E

0.0

P/B

0.59

Book value

$3.47

EPS (TTM)

$-6.78

52-week high

$42.00

52-week low

$1.96

50-day MA

$2.88

200-day MA

$11.03

Beta

0.45

Analyst view

Analysts rate Icecure Medical a buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $22.67.

Shareholding

Insiders

45.80%

Institutions

12.60%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	1.95%
Gunderson Capital Management Inc	0.43%
UBS Group AG	0.11%
HRT FINANCIAL LLC	0.03%
Geode Capital Management, LLC	0.03%
Hudson Bay Capital Management LP	0.02%
Morgan Stanley - Brokerage Accounts	0.01%
Foundations Investment Advisors, LLC	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Icecure Medical — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.